B. longum CKD1 enhances the efficacy of anti-diabetic medicines through upregulation of IL- 22 response in type 2 diabetic mice,Gut Microbes

当前位置： X-MOL 学术 › Gut Microbes › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

B. longum CKD1 enhances the efficacy of anti-diabetic medicines through upregulation of IL- 22 response in type 2 diabetic mice
Gut Microbes ( IF 12.2 ) Pub Date : 2024-02-23 , DOI: 10.1080/19490976.2024.2319889
Won Jun Kim ₁ , Bum Ju Kil ₁ , Chaewon Lee ₁ , Tae Young Kim ₂ , Goeun Han ₂ , Yukyung Choi ₃ , Kyunghwan Kim ₃ , Chang Hun Shin ₃ , Seung-Young Park ₄ , Heebal Kim _{1,

5} , Myunghoo Kim ₂ , Chul Sung Huh _{4,

6}

Affiliation

The gut microbiota plays a pivotal role in metabolic disorders, notably type 2 diabetes mellitus (T2DM). In this study, we investigated the synergistic potential of combining the effects of Bifidob...

中文翻译：